Bihag, Floramie B.

HRN: 17-03-35  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2025
COTRIMOXAZOLE 960MG (TAB)
04/10/2025
04/17/2025
PO
960mg
BID
Acute Uncomplicated Pyelonephritis
Waiting Final Action 

Indication:  Culture-directed    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: